Ocular Therapeutix, Inc. (NASDAQ:OCUL) Q2 2025 Earnings Call Transcript August 5, 2025
Ocular Therapeutix, Inc. misses on earnings expectations. Reported EPS is $-0.39291 EPS, expectations were $-0.35.
Operator: Good morning, and welcome to the Ocular Therapeutix Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded and will be available for replay on the Investor Relations section of the Ocular Therapeutix website. I...
